Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Cell Impact

0.02 SEK-6.67 %20/11 17:25
Less than 1K followers

CI

First North Stockholm

Industrial Goods & Services

Industrials

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-6.67 %
-8.20 %
-72.32 %
-87.48 %
-85.52 %
-94.26 %
-99.33 %
-99.96 %
-99.31 %

Cell Impact is a technology company focused on the industrial sector. The company produces and supplies flow plates and production technology to fuel cell manufacturers. The company has developed and patented a method for high-speed forming (adiabatic high-velocity forming) that makes it possible to manufacture flow plates with high energy density. The largest market is found in the transportation sector, with a focus on warehouse vehicles, buses and light trucks as well as passenger cars.

Read more
Market cap
22.29M SEK
Turnover
92.25K SEK
Revenue
5.57M
EBIT %
-2,296.59 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
8/12
2026

Extraordinary general meeting '26

12/2
2027

Annual report '26

22/4
2027

General meeting '27

Press release2026-11-18 09:01

Analyst Group: Aktieanalys på Cell Impact - Orderkonvertering och finansiering i fokus

Cell Impact
Regulatory press release2026-11-18 08:03

The last day of trading in warrants of series TO5 in Cell Impact is today, 18 November 2026

Cell Impact
Regulatory press release2026-11-18 08:03

Sista dag för handel med teckningsoptioner av serie TO5 i Cell Impact är idag den 18 november 2026

Cell Impact

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release2026-11-09 14:48

Analyst Group: Analyst Group kommenterar Cell Impacts Q3-rapport

Cell Impact
Regulatory press release2026-11-09 08:03

The subscription price for the exercise of warrants of series TO5 in Cell Impact has been determined to SEK 0.05, and the exercise period commences today, November 9, 2026

Cell Impact
Regulatory press release2026-11-09 08:03

Teckningskursen för nyttjandet av teckningsoptioner av serie TO5 i Cell Impact har fastställts till 0,05 SEK och nyttjandeperioden inleds idag den 9 november 2026

Cell Impact
Regulatory press release2026-11-06 08:03

Cell Impact Q3 2026: Nya möjligheter i ett fortsatt utmanande läge

Cell Impact
Regulatory press release2026-11-06 08:03

Cell Impact Q3 2026: New opportunities despite continuing challenges

Cell Impact
Regulatory press release2026-11-05 10:26

Kallelse till extra bolagsstämma i Cell Impact AB (publ)

Cell Impact
Regulatory press release2026-11-05 10:26

Notice of the Extraordinary General Meeting of Cell Impact AB (publ)

Cell Impact
Regulatory press release2026-11-02 12:50

Cell Impact utvärderar nanokristallint titan för icke namngivna kunder

Cell Impact
Regulatory press release2026-11-02 12:50

Cell Impact to evaluate NC titanium for undisclosed customers

Cell Impact
Regulatory press release2026-10-07 12:54

Cell Impact announces acceleration of previously communicated order from US customer

Cell Impact
Regulatory press release2026-10-07 12:54

Cell Impact tillkännager tidigareläggning av tidigare kommunicerad order från amerikansk kund

Cell Impact
Regulatory press release2026-10-02 08:03

Cell Impact utser Mangold till likviditetsgarant

Cell Impact
Regulatory press release2026-10-02 08:03

Cell Impact appoints Mangold as liquidity provider

Cell Impact
Regulatory press release2026-09-23 10:42

Cell Impact utser Mangold Fondkommission till ny Certified Adviser

Cell Impact
Regulatory press release2026-09-23 10:42

Cell Impact appoints Mangold Fondkommission as new Certified Adviser

Cell Impact
Regulatory press release2026-09-01 19:35

Cell Impact genomför en riktad emission till garanten i samband med den genomförda företrädesemissionen

Cell Impact
Regulatory press release2026-09-01 19:35

Cell Impact carries out a directed share issue to the underwriter in connection with the completed rights issue

Cell Impact